Vanilloid receptors (VR) integrate various painful stimuli, e.g., noxious heat, acidic pH, capsaicin, and resiniferatoxin (RTX). Although VR antagonists may be useful analgesics, the available agents capsazepine and ruthenium red lack the necessary potency and selectivity. Recently, submicromolar concentrations of the arginine-rich hexapeptide RRRRWW-NH 2 (R 4 W 2 ) blocked VR-mediated ionic currents in a Xenopus expression system in a noncompetitive and nonstereoselective manner. Here, VR-antagonistic effects of L-R 4 W 2 and D-R 4 W 2 , hexapeptides consisting entirely of L-and D-amino acids, were characterized in native adult rat dorsal root ganglion neurons using [Ca 2ϩ ] i imaging (Fura-2/acetoxymethyl ester). Fura-2 fluorescence ratio (R) was increased by RTX and capsaicin by 0.473 Ϯ 0.098 unit above basal levels of 0.903 Ϯ 0.011 (R max , 2.289 Ϯ 0.031; R min , 0.657 Ϯ 0.007) in a concentration-dependent manner (log EC 50 : RTX, Ϫ10.04 Ϯ 0.05, n ϭ 10; capsaicin, Ϫ6.60 Ϯ 0.10, n ϭ 11). Agonist concentration-response curves were shifted to the right by L-and D-R 4 W 2 (0.1, 1, and 10 M each) and by capsazepine (3, 10, 30, and 100 M), whereas their maximal effects and slopes remained unaffected, indicating competitive antagonism. Schild analysis for L-R 4 W 2 yielded apparent dissociation constants of 4.0 nM (RTX) and 3.7 nM (capsaicin), and slopes smaller than unity (RTX, 0.38; capsaicin, 0.42). Apparent dissociation constants and slopes for D-R 4 W 2 and capsaicin were 153 nM and 0.67 versus 4.1 M and 1.19 for capsazepine and capsaicin. Thus, VR-mediated effects in native dorsal root ganglion neurons were antagonized by L-R 4 W 2 Ͼ D-R 4 W 2 Ͼ capsazepine (order of potency). In conclusion, the R 4 W 2 hexapeptide is a potent, stereospecific, and (probably) competitive VR antagonist, although an allosteric interaction cannot be completely ruled out.
Vanilloid receptors are activated by capsaicin, the pungent principle of chili pepper, resiniferatoxin (RTX) isolated from Euphorbia resinifera, and some other naturally occurring or synthesized compounds (for reviews see Holzer, 1991; Szallasi and Blumberg, 1999; Caterina and Julius, 2001 ). Since vanilloid receptors are located primarily on mammalian unmyelinated sensory C-fibers in dorsal root ganglia, their activation by tissue injury (nociception) ultimately leads to a conscious sensation of pain. Because the initial excitation of vanilloid receptors by agonists such as capsaicin or RTX is followed by long-lasting desensitization, these compounds are, despite their pungency, therapeutically used for the treatment of chronic pain states (Cruz et al., 1997; Hautkappe et al., 1998; Szallasi and Blumberg, 1999) .
The recently cloned vanilloid receptor 1 (VR1; rat : Caterina et al., 1997; human: Hayes et al., 2000) forms a Ca 2ϩ -permeable, nonselective cation channel that is currently believed to serve as an integrator of various painful stimuli such as capsaicin, RTX, noxious heat, acidic pH (Caterina et al., 1997; Tominaga et al., 1998; Caterina et al., 2000; Caterina and Julius, 2001; Greffrath et al., 2001; Savidge et al., 2001) , and the endocannabinoid anandamide Olah et al., 2001) , particularly in inflamed tissue (Vyklicky et al., 1998) . Furthermore, acidic conditions (Tominaga et al., 1998; McLatchie and Bevan, 2001) , inflammatory mediators (bradykinin, serotonin, substance P: Vyklicky et al., 1998) , cyclooxygenase and lipoxygenase products (prostaglandin E 2, Vyklicky et al., 1998; leukotriene B 4 , 12-(S)-hydroperoxyeicosatetraenoic acid, Hwang et al., 2000) , phosphorylation by protein kinases A and C (Premkumar and Ahern, 2000) , and ATP-mediated activation of metabotropic P2Y-receptors (Tominaga et al., 2001 ) may act in unison to sensitize vanilloid receptors for noxious stimuli, thence lowering pain threshold and causing hyperalgesia .
However, only a few vanilloid receptor antagonists are available to date. Among them, capsazepine is a relatively weak competitive antagonist that has nonspecific effects at concentrations often required for antagonist activity, and ruthenium red is a weak and noncompetitive antagonist with a poorly defined mechanism of action (Bevan et al., 1992; Caterina et al., 1997; Docherty et al., 1997; Liu and Simon, 1997; Wardle et al., 1997 ; for reviews see Szallasi and Blumberg, 1999; Caterina and Julius, 2001 ). It was not until recently that three novel vanilloid receptor antagonists were described: the nonpungent capsaicin analog SDZ 249-665 (Urban et al., 2000) , the highly potent compound iodo-RTX (Wahl et al., 2001) , and the arginine-rich hexapeptide RRRRWW-NH 2 (R 4 W 2 ; Planells-Cases et al., 2000) . Although the latter compound noncompetitively blocks recombinant VR1 channels expressed in Xenopus oocytes with submicromolar potency, its activity in native cells has yet to be ascertained. Here, we report that in primary cultures of adult rat dorsal root ganglion neurons, the arginine-rich hexapeptide R 4 W 2 competitively antagonized the effects of capsaicin and RTX. The hexapeptide consisting entirely of L-amino acids, L-R 4 W 2 , was more potent than the respective stereoisomer D-R 4 W 2 .
Materials and Methods
Chemicals. Collagenase (type A, C-9891), 7S-nerve growth factor (N-0513), ITS-supplement (insulin-transferrin-selenium, I-3146), poly-L-lysin, trypan blue, ionomycin, digitonin, capsaicin, capsazepine, resiniferatoxin, and FITC-labeled Bandeiraea simplicifolia isolectin B 4 were obtained from Sigma Chemie (Deisenhofen, Germany). Dispase and DNase-1 were obtained from Roche Diagnostics (Mannheim, Germany) and Fura-2/acetoxymethyl ester from Molecular Probes (Eugene, OR). The D-and L-enantiomers of the argininerich hexapeptide R 4 W 2 (sequence RRRRWW-NH 2 , purity Ͼ99.0% by high-performance liquid chromatography analysis) were gifts from Grü nenthal (Aachen, Germany). All other chemicals were obtained at the highest available purity from Sigma or other commercial suppliers. Sterile disposable plastic ware for cell culture was by Falcon (BD Biosciences, Heidelberg, Germany), Nunc (Wiesbaden, Germany), or Nalgene (Nalge, Brussels, Belgium). Media, supplements, and trypsin for cell culture were obtained from Invitrogen (Eggenheim, Germany), and fetal bovine serum was obtained from Seromed (Berlin, Germany). Drugs were dissolved in water, methanol, or dimethyl sulfoxide and stored at Ϫ20°C. Aliquots of the stock solutions were diluted directly into the bath solution to achieve the final concentration. Solvents did not influence [Ca 2ϩ ] i measurements.
Isolation and Culture of Rat Dorsal Root Ganglion Cells. The present investigation was conducted in accordance with the principles outlined in the Declaration of Helsinki and the German law governing the Care and Use of Laboratory Animals, and was approved by the representative for animal care and use of the University of Leipzig. Adult rats (age 6 -8 weeks) were killed by CO 2 and decapitation. Thoracic and abdominal organs were quickly removed, the spines were chilled at 4°C in Ca 2ϩ /Mg 2ϩ -free Hanks' balanced salt solution (HBSS), and thoracic and lumbar dorsal root ganglia were dissected and freed from connective tissue using fine tweezers and scissors under sterile conditions. Dorsal root ganglia collected in chilled HBSS were centrifuged (5 min, 124g) and resuspended in HBSS containing collagenase (0.5 mg/ml), dispase (1 mg/ml), and DNase-1 (1 mg/ml). After 40 to 50 min of incubation at 37°C in a shaking water bath, trypsin (0.6 mg/ml) was added for a further 15 min of incubation. After addition of medium 1 (Dulbecco's minimal essential medium, 35 mM total glucose, 2.5 mM L-glutamine, 15 mM HEPES, 50 g/ml gentamicin, 5% fetal bovine serum) to deactivate enzymes, the cell suspension was mechanically triturated using firepolished Pasteur pipettes and passed through a cell strainer (mesh size 70 m) to remove undigested tissue fragments. After centrifugation of the cell suspension (5 min at 194g), the pellet was resuspended in medium 1 supplemented with 30 ng/ml nerve growth factor, 10 g/ml insulin, 5.5 g/ml transferrin, and 5 ng/ml selenium. DRG cells were plated at a density of 2 ϫ 10 4 cells/ml onto poly(Llysin)-coated (25 g/ml) glass coverslips. Cultures were maintained for 2 to 4 days in a humidified atmosphere (37°C, 5% CO 2 ) before experimentation.
Intracellular Calcium Measurements. DRG cell cultures from days 2 to 4 were loaded for 50 to 60 min at 37°C in the dark with the cell permeant acetoxymethyl ester of the fluorescent Ca 2ϩ indicator Fura-2 (1 M). Simultaneously, cells were exposed to the FITClabeled Bandeiraea simplicifolia isolectin IB 4 (0.1-0.5 g/ml). To remove excess extracellular Fura-2 and IB 4 , glass coverslips were washed several times with a modified Tyrode's solution (40.0 mM NaCl, 4.5 mM KCl, 2.0 mM CaCl 2 , 1.0 mM MgCl 2 , 10.0 mM HEPES, 10.0 mM glucose; pH adjusted to 7.4 with NaOH) and were allowed to rest for 30 min at room temperature protected from light. Thereafter, Ca 2ϩ imaging experiments were performed at room temperature in Tyrode's solution using an inverted microscope (IX-70; Olympus, Hamburg, Germany) equipped for epifluorescence and a Peltiercooled charge-coupled device camera (IMAGO; Till Photonic Inc., Martinsried, Germany). Intracellular Fura-2 was alternately excited at 340 nm and at 380 nm, and the emitted light was measured at a wavelength of 510 nm. The TILL visION software (release 3.3; Till Photonic Inc.) was used for data acquisition, system control, and, later, off-line data analysis.
Phase-contrast microphotographs taken at both the beginning and the end of an experiment served as documentation for the size (major and minor diameter averaged), integrity, and morphological nature of DRG cells. An ellipsoid-ovoid-spherical morphology was considered characteristic for neurons in contrast to the polygonal-flatspindle-like shape of non-neuronal cells. In addition, a fluorescence image (excitation at 470 nm, emission at 510 nm) was recorded at the beginning of experiments for later quantification of FITC-IB 4 labeling of DRG cells. The fluorescence ratio (340 nm/380 nm) provides a relative measure of the cytosolic-free Ca 2ϩ concentration ([Ca 2ϩ ] i ; Grynkiewicz et al., 1985) . The dynamic range of the observed fluorescence ratios was determined by measuring maximal and minimal fluorescence ratios, R max and R min . Sequential exposure of cells for 150 s each to a Tyrode's solution with high K ϩ (50 mM) containing 10 mM CaCl 2 and 10 M ionomycin, and a nominally Ca 2ϩ -free Tyrode's solution containing 10 mM EGTA and 0.01% digitonin defined R max and R min , respectively. Averaging the results of several neurons, R max amounted to 2.289 Ϯ 0.031, and R min was 0.657 Ϯ 0.007 (n ϭ 274). Because DRG neurons generally express high-voltage activated calcium channels (Petersen and LaMotte, 1991; Scroggs and Fox, 1992) , only neurons tested for excitability and viability by depolarization with a high-KCl (50 mM) Tyrode's solution were included in the evaluation of data.
The experimental protocol routinely used started with the application of Tyrode's solution via the flush valve of a pressure-operated, computer-controlled rapid drug application device (DAD-12; NPI Electronic GmbH, Tamm, Germany), followed by high-K ϩ Tyrode's solution (94.5 mM NaCl, 50.0 mM KCl, 2.0 mM CaCl 2 , 1.0 mM MgCl 2 , 10.0 mM HEPES, 10.0 mM glucose; pH adjusted to 7.4 with NaOH) for 2 s. When the fluorescence ratio had returned to baseline after 3 min, a saturating concentration of ATP (500 M) in nominally Ca 2ϩ -free Tyrode's solution supplemented with 0.5 mM EGTA was applied for 2 s as a test for metabotropic P2Y purinoceptors (data not shown; please see first gap in time axis in Fig. 1 ). Five minutes later, the vanilloid receptor agonists capsaicin and RTX were applied either alone or in the presence of antagonists such as capsazepine and R 4 W 2 (antagonist exposure started 60 s before and lasted until 30 s after the agonist exposure). Since both capsaicin and RTX had a jpet.aspetjournals.org rapid onset but a very slow decay of effect, the vanilloid receptor agonists were applied in a cumulative manner with an alternating 2 s of agonist exposure and a 6-s interval. The very slow decay of effect and the often incomplete return to baseline, even after extended periods of washout (10 -15 min), restricted the application of capsaicin and RTX to the end of each experiment.
Statistical Analysis. Results were expressed as mean values Ϯ S.E.M. of n experiments if not indicated otherwise. Concentrationresponse curves were fitted to individual data sets using the following standard four-parameter logistic equation
with minimal and maximal effect (min, max), half-maximal excitatory drug concentration (EC 50 ), drug concentration [D], and Hill slope n H . The minimal effect was treated as a constant (ϭ 0) throughout, whereas the other parameters were variables. Statistical differences were analyzed by means of ANOVA followed by Dunnett's test versus the respective control group and considered significant at p Ͻ 0.05. If a nonparametric test was required, ANOVA on ranks followed by Dunn's test versus the control group was applied.
Results
In Fig. 1 (Fig. 1) . On average, KCl-induced depolarization increased the fluorescence ratio in neurons (as defined by their ellipsoid-ovoidspherical shape) by 0.359 Ϯ 0.013 over baseline levels of 0.862 Ϯ 0.008 (n ϭ 397, p Ͻ 0.05), whereas in non-neuronal cells (as defined by their polygonal-flat-spindle-like morphology), KCl-induced depolarization had a significantly smaller effect (ratio increase by 0.081 Ϯ 0.016, basal ratio 0.750 Ϯ 0.019, n ϭ 60, p Ͻ 0.05). These results are consistent with the presence of voltage-gated Ca 2ϩ channels in neurons and their near absence in the accompanying non-neuronal cells.
The experiment continued by exposing the neuron to increasing concentrations of capsaicin (Fig. 1) . Although rapid in onset, the VR-induced increase in [Ca 2ϩ ] i was sustained whether or not the agonists capsaicin (Fig. 1) or RTX (not shown) continued to be present, thus allowing the establishment of cumulative agonist concentration-response curves. The slow decline of agonist-induced elevated [Ca 2ϩ ] i levels toward baseline values is illustrated in the right part of Fig.  1 . Even after prolonged washout (Ն10 min) of either agonist, [Ca 2ϩ ] i signals remained elevated at approximately 50% of the maximum agonist effect as described before (Cholewinski et al., 1993) . Both VR agonists, capsaicin and RTX, produced concentration-dependent increases in [Ca 2ϩ ] i at micromolar and nanomolar concentrations, respectively (Fig. 1 , representative experiment; Fig. 2, average) . Maximal increases in fluorescence ratio above baseline values were similar for capsaicin (0.511 Ϯ 0.074, n ϭ 145) and for RTX (0.476 Ϯ 0.080, n ϭ 77; not significant). Half-maximal effects were reached with 0.25 M capsaicin and with 0.091 nM RTX (compare Table 1 for complete list of parameters of concentration-response curves); these values are in line with published data McIntyre et al., 2001 ; for reviews see Szallasi and Blumberg, 1999; Caterina and Julius, 2001 ).
Concentration-response curves obtained with either VR agonist, capsaicin or RTX, were shifted to the right in the presence of the well characterized VR antagonist capsazepine (Table 1 ). The magnitude of this shift was significantly dependent on the concentration of capsazepine, whereas maximum effects of capsaicin and the Hill slopes of the respective concentration-response curves were not affected (Table 1) , indicating a competitive antagonism of capsazepine at vanilloid receptors. Both RTX and capsaicin concentration-response curves were also shifted to the right by the arginine-rich hexapeptides L-R 4 W 2 and D-R 4 W 2 in a concentration-dependent manner (Table 1) . The antagonist effect of L-R 4 W 2 was already significant at 0.1 M, the lowest concentration tested, whereas the same concentration of D-R 4 W 2 did not yet shift agonist concentration-response curves ( Fig. 2 ). This effect suggests a stereoselectivity of VR block by the hexapeptides, the L-enantiomer being a more potent antagonist than D-R 4 W 2 . Since neither the maximum agonist effects nor the Hill slopes of concentration-response curves were affected by either hexapeptide enantiomer, the mechanism of antagonist action of L-R 4 W 2 and D-R 4 W 2 may be a competitive one, too.
To characterize the mechanism of antagonist action of the hexapeptide enantiomers in more detail, a Schild analysis was performed, the results of which are depicted in Fig. 3 . Because only one concentration-response curve could be established in each set of neurons due to the incomplete reversibility of agonist effects within reasonable times, concentration ratios for the Schild analysis were estimated based on the mean EC 50 values for the individual experimental groups listed in Table 1 . The concentration ratio data so obtained were subject to linear regression analysis with the exception of D-R 4 W 2 and RTX, where a linear relation between log(CR Ϫ 1) and antagonist concentration was apparently not obvious (Fig. 3A) . Linear regression analysis of the data obtained with L-R 4 W 2 and RTX or capsaicin yielded similar results. The apparent dissociation constants of L-R 4 W 2 were 4.0 nM and 3.7 nM with RTX and capsaicin, respectively, as agonists. However, the regression lines were shallow, possessing slopes of 0.38 Ϯ 0.01 (RTX) and 0.42 Ϯ 0.04 (capsaicin) that were significantly smaller than unity (p Ͻ 0.05). With capsaicin as agonist, regression analysis yielded apparent antagonist dissociation constants of 153 nM for D-R 4 W 2 and 4.1 M for capsazepine, and slopes of 0.67 Ϯ 0.06 (D-R 4 W 2 ) and 1.19 Ϯ 0.28 (capsazepine), which were significantly smaller than and indistinguishable from unity, respectively. Although these results support the notion of a stereoselectivity of block of vanilloid receptors by the hexapeptide enantiomers, with L-R 4 W 2 being more potent than D-R 4 W 2 , they also suggest that the interaction between arginine-rich hexapeptides and the vanilloid receptor may not be as stoichiometric as that between capsazepine and VR.
Discussion
We have demonstrated for the first time in native rat dorsal root ganglion neurons, which are the most important peripheral integration site for noxious stimuli, that the positively charged arginine-rich hexapeptide R 4 W 2 antagonizes vanilloid receptor-mediated effects in a stereoselective manner, with the peptide consisting of L-amino acids, L-R 4 W 2 , being more potent than D-R 4 W 2 . Both stereoisomers antagonized capsaicin-and RTX-induced [Ca 2ϩ ] i increases in an apparently competitive manner; however, the significant deviation from unity of Hill coefficients of concentration-response curves and of Schild plots is incompatible with the presence of a single binding site.
Thus, the present investigation confirms in native dorsal root ganglion neurons the potent (submicromolar) vanilloid receptor antagonist activity of the arginine-rich hexapeptide R 4 W 2 that has been described recently in a Xenopus expression system (Planells-Cases et al., 2000) , although the mechanism of antagonist action and its putative stereoselectivity are controversial. R 4 W 2 blocked capsaicin-induced currents mediated by heterologously expressed VR1 channels in an apparently noncompetitive manner because of virtually iden- Values are mean Ϯ S.E.M. of n experiments; maximum is expressed as increase in Fura-2 fluorescence ratio (340 nm/380 nm) above baseline ratio. Statistical differences were analyzed by ANOVA, followed by Dunnett's multiple comparisons test versus control, with control being either capsaicin without antagonist or RTX without antagonist. tical capsaicin EC 50 concentrations in the absence and in the presence of the hexapeptide (Planells-Cases et al., 2000) . In contrast, our results rather suggest the presence of a competitive antagonism since concentration-response curves for RTX and capsaicin were simply shifted along the concentration axis in the presence of R 4 W 2 without maximum response or slope being affected ( Fig. 2 ; Table 1 ). Notwithstanding the possibility of more or less subtle differences in the properties of recombinant vanilloid receptors in a nonmammalian expression system versus native vanilloid receptor in DRG neurons in terms of VR1 homo-/ hetero-oligomers, glycosylation state, or interacting modulatory proteins (Planells-Cases et al., 2000; Jahnel et al., 2001; Kedei et al., 2001) , the present shift to the right of VR agonist concentration-response curves without a change in the maximum effect could not only be attributed to competitive antagonism (Clements and Westbrook, 1994) , but might also reflect an allosteric interaction (Li et al., 1997 (Li et al., , 1998 . If R 4 W 2 acted competitively at the capsaicin or RTX binding site, increasing hexapeptide concentrations would be expected to shift the agonist concentration-response curve to the right in a progressive and (almost) indefinite manner. Such a progressive shift was indeed observed with R 4 W 2 concentrations over two orders of magnitude before limited drug supplies and elevated solvent concentrations precluded further experiments. If R 4 W 2 acts at an allosteric site, the hexapeptide should cease to shift agonist concentration-response curves when its allosteric site(s) of action is(are) saturated; however, the corresponding curvilinear Schild plot reaching a limiting value at high concentrations of the antagonist R 4 W 2 was not observed. Another method to discriminate between competitive and allosteric interaction relies on measuring activation and inactivation rates of vanilloid receptor channels, where a competitive antagonist will decrease the activation rate without changing the deactivation rate (Clements and Westbrook, 1994) , whereas an increased deactivation rate and an unaffected activation rate are characteristic of an allosteric interaction (Li et al., 1997 (Li et al., , 1998 . However, this approach was unsuccessful since experimental conditions without desensitization of capsaicin-activated currents could not be satisfactorily established (data not shown).
Another putative explanation for the discrepancy between the results of Planells-Cases et al. (2000) and those of the present paper may become possible when considering the particular properties of cells (Xenopus expression system versus native rat dorsal root ganglion neurons) and signal detection methods used (voltage-clamp versus Ca 2ϩ imaging). In the Xenopus expression system, the major, if not only, inward current (directly measured by means of the voltageclamp technique) is mediated by recombinant vanilloid receptors, the block of which attenuates the maximal inward current flow, thus resembling a noncompetitive antagonism. Dorsal root ganglion neurons, on the other hand, possess a variety of ligand-and voltage-gated cation channels, and by means of Ca 2ϩ imaging, the contribution from all participating Ca 2ϩ sources (active Ca 2ϩ conduits) is integrated. Na ϩ and Ca 2ϩ influx via capsaicin-or RTX-activated vanilloid receptors is assumed to depolarize the neuron, thus serving as the trigger for opening of voltage-dependent Ca 2ϩ channels. This is consistent with observations that VR-mediated [Ca 2ϩ ] i signals were depressed by removal of extracellular Na ϩ or by dihydropyridine block of voltage-dependent Ca 2ϩ channels (data not shown; Greffrath et al., 2001) . Since a very small inward current of only a few picoamperes may suffice as trigger for a large depolarization and the ensuing full-size Ca 2ϩ influx, the maximal signal detected by Ca 2ϩ imaging may be preserved even when the trigger, i.e., the cation current via vanilloid receptor channels, is markedly reduced, thus resembling a competitive antagonism. In terms of a putative stereoselective mechanism of action, it has been reported that equal concentrations of L-R 4 W 2 and D-R 4 W 2 , blocked heterologously expressed VR1 channels with similar efficacy, suggesting lack of stereoselectivity of block, whereas only the D-hexapeptide significantly decreased capsaicin-induced ocular irritation in mice, seemingly because it is proteolysis-resistant (Planells-Cases et al., 2000) . In contrast, the present results clearly support the conclusion of a stereoselective antagonism with L-R 4 W 2 being more potent than D-R 4 W 2 ( Fig. 2; Table 1 ). Membrane-bound extracellularly oriented peptidases acting on a broad range of substrates occur throughout the nervous system in and ex vivo (Konkoy and Davis, 1996) and also in mixed neuronal/ glial cell cultures from dorsal root ganglia (Berger et al., 1995) . However, an ostensible stereoselectivity due to preferential proteolytic degradation of one of the hexapeptide enantiomers is discounted, because the "physiological" L-R 4 W 2 is expected to be more susceptible to proteolysis than D-R 4 W 2 , whereas the latter was clearly less potent than the former.
Furthermore, Hill coefficients around unity are consistent with the occurrence of a single binding site in heterologously expressed vanilloid receptors (Planells-Cases et al., 2000) , whereas in rat dorsal root ganglion neurons the results from Schild analysis are incompatible with a single binding site, suggesting, instead, the presence of several binding sites (Fig. 3) . One of these several putative binding sites is most likely located on the pore loop of the vanilloid receptor, because the amino acid sequence of the pore loop contains four negatively charged residues (E636, D646, E648, and E651) that may constitute a binding site for positively charged molecules. Although this very binding site apparently does not discriminate between L-R 4 W 2 and D-R 4 W 2 (PlanellsCases et al., 2000) , other arginine-rich hexapeptide binding sites do so, e.g., N-methyl-D-aspartate (NMDA) receptors where D-R 4 W 2 has been reported to be twice as potent as L-R 4 W 2 (Ferrer-Montiel et al., 1998) . Thus, one might speculate that the large number of NMDA receptors present in rat dorsal root ganglion neurons preferentially bind D-R 4 W 2 , thus acting as a sink for the D-hexapeptide, thereby resulting in the observed apparent stereoselective antagonism at vanilloid receptors.
In conclusion, both synthetic (e.g., R 4 W 2 ) and naturally occurring (e.g., dynorphin A) arginine-rich hexapeptides have been demonstrated to possess antagonist activity at NMDA and vanilloid receptors (Ferrer-Montiel et al., 1998; Planells-Cases et al., 2000; present paper) , which constitute important sites within the pain pathway for integration of noxious stimuli. The present data are consistent with R 4 W 2 acting as a stereoselective and competitive antagonist at native vanilloid receptors in dorsal root ganglion neurons, although an allosteric interaction cannot be totally excluded. Future work will show whether it will be possible to develop a low molecular weight molecule that mimics the antagonist action of arginine-rich hexapeptides at NMDA and vanilloid receptors and may prove a useful analgesic for the treatment of chronic pain.
